Anti-myeloma effects of ruxolitinib combined with...

Cancer Letters 2017 / 09 Vol. 403

Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients

de Oliveira, Mariana B., Fook-Alves, Veruska L., Eugenio, Angela I.P., Fernando, Rodrigo C., Sanson, Luiz Felipe G., de Carvalho, Mariana F., Braga, Walter M.T., Davies, Faith E., Colleoni, Gisele W.B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
403
Language:
english
Journal:
Cancer Letters
DOI:
10.1016/j.canlet.2017.06.016
Date:
September, 2017
File:
PDF, 1.90 MB
english, 2017
Conversion to is in progress
Conversion to is failed